logoThe People's Perspective on Medicine

Most Americans Are Still Vulnerable to COVID-19

A study of SARS-2 antibodies in blood tests shows many more people were infected than tested. Yet the vast majority of us are still vulnerable to COVID-19.
Most Americans Are Still Vulnerable to COVID-19
Novel Coronavirus blood test Concept. Nurse holding test tube with blood for 2019-nCoV analyzing.

Antibodies reveal who has been infected with the SARS-CoV-2 virus. According to the latest research, the vast majority of US residents remain vulnerable to COVID-19, the disease caused by SARS-2.

What Does the Study Tell Us About How Many May Be Vulnerable to COVID-19?

Between March and mid-May, researchers tested blood samples in ten different regions to see how many people showed antibodies to the coronavirus spike protein (JAMA Internal Medicine, online July 21, 2020). Technicians drew most of these samples for other purposes, such as testing cholesterol levels. Then the researchers got permission to use them for coronavirus antibody testing as well.

These blood tests of more than 16,000 people demonstrated that the vast majority of Americans had not been exposed to the virus at that point. As a result, they were still vulnerable to COVID-19. For example, about 1% of the samples from the San Francisco Bay area had antibodies, compared to nearly 7% of those from metropolitan New York.

How Do People With Antibodies Compare to Known COVID-19 Cases?

The scientists note that although the prevalence of antibodies was low, it was higher than the number of confirmed cases. This suggests that troubles with testing led to underreporting. In places, the prevalence of antibodies was ten times higher than the prevalence of reported cases. New York City, San Francisco and western Washington state all fit that description. In other areas, the antibody prevalence was just six times higher than previously counted cases. At the extreme, in Missouri, antibodies indicated 24 times more people had been infected with the virus.

We don’t yet know if antibodies to the virus confer protection from a second infection. Consequently, even those who have recovered from the disease might still be vulnerable to COVID-19. Until we have effective vaccines, we all need to keep washing our hands and wearing our masks. Staying six feet or more apart is also critical, but the most important thing–if you feel sick, stay home!

Rate this article
star-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-emptystar-fullstar-empty
4.1- 63 ratings
About the Author
Terry Graedon, PhD, is a medical anthropologist and co-host of The People’s Pharmacy radio show, co-author of The People’s Pharmacy syndicated newspaper columns and numerous books, and co-founder of The People’s Pharmacy website. Terry taught in the Duke University School of Nursing and was an adjunct assistant professor in the Department of Anthropology. She is a Fellow of the Society of Applied Anthropology. Terry is one of the country's leading authorities on the science behind folk remedies. .
Get the latest health news right in your inbox

Join our daily email newsletter with breaking health news, prescription drug information, home remedies AND you'll get a copy of our brand new full-length health guide — for FREE!

Screenshots of The People's Pharmacy website on mobile devices of various sizes
Citations
  • Havers FP et al, "Seroprevalence of antibodies to SARS-CoV-2 in 10 sites in the United States, March 23-May 12, 2020." JAMA Internal Medicine, online July 21, 2020. doi:10.1001/jamainternmed.2020.4130
Join over 150,000 Subscribers at The People's Pharmacy

We're empowering you to make wise decisions about your own health, by providing you with essential health information about both medical and alternative treatment options.